440 research outputs found

    The Pain Divide: a cross-sectional analysis of chronic pain prevalence, pain intensity and opioid utilisation in England

    Get PDF
    Objectives: Our central research question was, in England, are geographical inequalities in opioid use driven by health need (pain)? To answer this question, our study examined: (1) if there are regional inequalities in rates of chronic pain prevalence, pain intensity and opioid utilisation in England; (2) if opioid use and chronic pain are associated after adjusting for individual-level and area-level confounders. Design: Cross-sectional study design using data from the Health Survey for England 2011. Setting England. Primary and secondary outcome measures: Chronic pain prevalence, pain intensity and opioid utilisation. Participants: Participant data relating to chronic pain prevalence, pain intensity and opioid usage data were obtained at local authority level from the Health Survey for England 2011; in total, 5711 respondents were included in our analysis. Methods: Regional and local authority data were mapped, and a generalised linear model was then used to explore the relationships between the data. The model was adjusted to account for area-level and individual-level variables. Results: There were geographical variations in chronic pain prevalence, pain intensity and opioid utilisation across the English regions—with evidence of a ‘pain divide’ between the North and the South, whereby people in the North of England more likely to have ‘severely limiting’ or ‘moderately limiting’ chronic pain. The intensity of chronic pain was significantly and positively associated with the use of opioid analgesics. Conclusions: There are geographical differences in chronic pain prevalence, pain intensity and opioid utilisation across England—with evidence of a ‘pain divide’. Given the public health concerns associated with the long-term use of opioid analgesics—and their questionable activity in the management of chronic pain—more guidance is needed to support prescribers in the management of chronic pain, so the initiation of opioids can be avoided

    Investigation of hypersonic flow in the vki h3 wind tunnel: From facility characterization to boundary-layer interaction over low-temperature ablators

    Get PDF
    This work deals with the characterization, in terms of operating conditions, of the H3 hypersonic wind tunnel of the von Karman Institute for Fluid Dynamics (VKI), thus providing a detailed and structured benchmark for the evaluation of testing capabilities in hypersonic wind tunnels, and with the experimental study of the interaction between the boundary layer and the ablation process of low temperature ablative materials. The flow characteristics of the test section of the H3 WT have been assessed by using a pitot rake, for a wider range of operating conditions with respect to previous calibrations. A CFD analysis of the diffuser-ejector system has been carried out to assess its performance, and an experimental test campaign has been performed in order to validate the CFD analyses and completely characterize the facility operating conditions. Finally, a series of experiments with models of increasing size and different shapes has been carried out to determine the blockage effect in the tunnel test section. The H3 WT is then employed to study the boundary layer interaction with the ablative process on low temperature ablative models. These models have been built after having appropriately designed the sintering system. The Planar Laser Induced Fluorescence method has been applied to visualize the flow behavior: a laminar-turbulent transition due to the ablation process has been observed, together with the main flow structures

    Antisera specific for D2 dopamine receptors

    Full text link

    Is basal ultrasensitive measurement of calcitonin capable of substituting for the pentagastrin-stimulation test?

    Get PDF
    OBJECTIVE: To evaluate a second-generation assay for basal serum calcitonin (CT) measurements compared with the pentagastrin-stimulation test for the diagnosis of inherited medullary thyroid carcinoma (MTC) and the follow-up of patients with MTC after surgery. Recent American Thyroid Association recommendations suggest the use of basal CT alone to diagnose and assess follow-up of MTC as the pentagastrin (Pg) test is unavailable in many countries. DESIGN: Multicentric prospective study. PATIENTS: A total of 162 patients with basal CT <10 ng/l were included: 54 asymptomatic patients harboured noncysteine \u27rearranged during transfection\u27 (RET) proto-oncogene mutations and 108 patients had entered follow-up of MTC after surgery. MEASUREMENT: All patients underwent basal and Pg-stimulated CT measurements using a second-generation assay with 5-ng/l functional sensitivity. RESULTS: Ninety-five per cent of patients with basal CT ≥ 5 ng/l and 25% of patients with basal CT <5 ng/l had a positive Pg-stimulation test (Pg CT >10 ng/l). Compared with the reference Pg test, basal CT ≥ 5 ng/l had 99% specificity, a 95%-positive predictive value but only 35% sensitivity (P < 0.0001). Overall, there were 31% less false-negative results using a 5-ng/l threshold for basal CT instead of the previously used 10-ng/l threshold. CONCLUSION: The ultrasensitive CT assay reduces the false-negative rate of basal CT measurements when diagnosing familial MTC and in postoperative follow-up compared with previously used assays. However, its sensitivity to detect C-cell disease remains lower than that of the Pg-stimulation test
    corecore